Metabolic

Cagrilintide

A long-acting amylin analog studied for appetite and weight, often with semaglutide.

What is Cagrilintide?

Cagrilintide is a long-acting amylin analog that influences appetite and satiety. It has been studied both on its own and in combination with semaglutide (as CagriSema) for weight management.

Also known as: Cagri, AM833

Commonly researched for

Appetite regulationWeight managementSatiety

Typically stacked with

Semaglutide

Research status

Clinical trials — investigational.

Important considerations

Investigational and not approved as a standalone product. Medical supervision advised.

View published research on PubMed
This page is for educational purposes only and is not medical advice, a diagnosis, or a recommendation to use any compound. It contains no dosing or purchase information. Always consult a licensed healthcare professional before considering any peptide.